Detalhe da pesquisa
1.
The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 30(13): 8353-8361, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658272
2.
Phyllodes tumours of the breast: a consensus review.
Histopathology
; 68(1): 5-21, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768026
3.
Menopausal status does not predict Oncotype DX recurrence score.
J Surg Res
; 198(1): 27-33, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095420
4.
Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas.
Mod Pathol
; 26(11): 1451-60, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23743933
5.
Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis.
Am J Dermatopathol
; 35(8): 813-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344009
6.
A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas.
Mod Pathol
; 25(4): 556-66, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22173289
7.
The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma.
Mod Pathol
; 25(2): 163-77, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22020194
8.
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.
Oncologist
; 16(11): 1520-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22016474
9.
Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor.
Sarcoma
; 2011: 971050, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21647307
10.
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Am J Pathol
; 174(4): 1504-14, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264915
11.
Gene expression profiling in breast cancer.
Cancer Control
; 17(3): 177-82, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664515
12.
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Cancer Res
; 67(7): 3177-84, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409425
13.
Nuclear orphan receptor TR3/Nur77 mediates melanoma cell apoptosis.
Cancer Biol Ther
; 6(3): 405-12, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17297306
14.
Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
Am J Surg Pathol
; 31(1): 129-40, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17197929
15.
Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Am J Surg Pathol
; 31(2): 304-10, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255777
16.
High-risk benign breast lesions: current strategies in management.
Cancer Control
; 14(4): 321-9, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17914332
17.
Survival and invasiveness of astrocytomas promoted by erythropoietin.
J Neurosurg
; 106(2): 338-50, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17410721
18.
Repeat operative sentinel lymph node biopsy.
Clin Breast Cancer
; 6(6): 530-2, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16595037
19.
Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
Appl Immunohistochem Mol Morphol
; 14(3): 324-7, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16932024
20.
Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
Melanoma Res
; 16(4): 275-83, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16845323